Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

1981 - 1990 of 3572 results found

Management of Diabetic Foot (Second Edition)

MeSH Terms
Diabetic Foot (C19.246.099.937.250); Diabetic Neuropathies (C19.246.099.937); Foot Ulcer (C17.800.321.250)
Publication Scope
assessment
diagnosis
prevention
rehabilitation
treatment
Countries of Application
Malaysia
Guideline Publication Status
Published
Languages
English
Authors
HTA DoH (MY)
Willingness to Collaborate
Yes
Publication Year
2018

Management of Diabetic Nephropathy

MeSH Terms
Kidney Diseases (C12.777.419); Diabetes Complications (C19.246.099); Endocrine System Diseases (C19); Urologic and Male Genital Diseases (C12); Diabetes Mellitus (C19.246)
Publication Scope
management
prevention
screening
Countries of Application
Malaysia
Guideline Publication Status
Published
Languages
English
Authors
HTA DoH (MY)
Publication Year
2004

Management of Drug Resistant-Tuberculosis

MeSH Terms
Tuberculosis, Multidrug-Resistant (C01.150.252.410.040.552.846.775); Tuberculosis (C01.150.252.410.040.552.846)
Publication Scope
assessment
diagnosis
management
prevention
treatment
Countries of Application
Malaysia
Guideline Publication Status
Published
Languages
English
Authors
HTA DoH (MY)
Willingness to Collaborate
Yes
Publication Year
2016

Management of ductal carcinoma in situ of the breast

MeSH Terms

Mastectomy (E04.466); Radiotherapy (E02.815); Tamoxifen (D02.455.426.559.389.150.700.900); Carcinoma; Intraductal; Noninfiltrating (C04.557.470.200.025.275)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Replaced
Languages
English
Authors
McMaster University (CA)
Publication Year
2018

Management of Ductal Carcinoma in Situ of the Breast

MeSH Terms

Carcinoma, Intraductal, Noninfiltrating, breast ductal carcinoma, recurrence score, 12 gene expression assay, Margin, Marginal

Guideline Contact
Lisa Durocher; [email protected]
Keywords
Ductal Carcinoma in Situ; DCIS; Breast Conserving Surgery; Mastectomy; Radiation; Tamoxifen; Anastrozole
Date for Review
The Program in Evidence-based Care (PEBC), Ontario Health (CCO) has an annual review process for each guideline. Guidelines are reviewed every fall, one year after they are completed.
Publication Date
March 31, 2024
Date of Last Evidence Search
November 27, 2023
Methods Applied
Evidence-based; Systematic review-based; External review; Evidence quality assessment; Patient/survivor/caregiver participation; GRADE approach
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2024

Management of Dyslipidaemia (5th Edition)

MeSH Terms
Hyperlipidemias (C18.452.584.500.500); Dyslipidemias (C18.452.584.500); Hypercholesterolemia (C18.452.584.500.500.396)
Publication Scope
assessment
diagnosis
prevention
treatment
Countries of Application
Malaysia
Guideline Publication Status
Published
Languages
English
Authors
HTA DoH (MY)
Willingness to Collaborate
Yes
Publication Year
2017

Management of early rheumatoid arthritis (SIGN CPG 123)

MeSH Terms
Musculoskeletal Diseases (C05); Joint Diseases (C05.550); Rheumatic Diseases (C05.799); Arthritis (C05.550.114)
Guideline Contact
Roberta James ([email protected])
Date for Review
2001-02-14
Publication Scope
assessment
management
Countries of Application
United Kingdom
Guideline Publication Status
Withdrawn
Languages
English
Authors
SIGN (GB)
Publication Year
2011
Buttons

Management of Early-Stage Hodgkin Lymphoma

MeSH Terms

Hodgkin Disease (C04.557.386.355); Antineoplastic Agents (D27.505.954.248); Antineoplastic Protocols (E02.183.750); Remission Induction (E02.860); Lymphoma (C04.557.386)

Guideline Contact
Cindy Walker-Dilks ([email protected])
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
PEBC (Program in evidenced-based care)
Publication Year
2023

Management of epithelial ovarian cancer (SIGN CPG 135)

MeSH Terms

Neoplasms (C04); Ovarian Neoplasms (C04.588.322.455); Clinical Laboratory Techniques (E05.200); Diagnostic Imaging (E01.370.350); Gynecologic Surgical Procedures (E04.950.300); Chemotherapy; Adjuvant (E02.319.170)

Guideline Contact
Roberta James ([email protected])
Date for Review
2001-11-16
Publication Scope
assessment
management
screening
Countries of Application
United Kingdom
Guideline Publication Status
Published
Languages
English
Authors
SIGN (GB)
Publication Year
2013
My Saved Lists